Fibronostics

Fibronostics

Hospitals and Health Care

Orlando, Florida 3,133 followers

An In vitro diagnostics platform for metabolic conditions detection and prognosis, powered by artificial intelligence.

About us

Fibronostics is a healthcare technology company providing algorithm-based solutions in a variety of diagnostic testing areas, focusing on assessing liver disease existence/progression, but also other chronic areas such as coronary heart disease, stroke, diabetes, and obstructive sleep apnea. Fibronostics' LIVERFASt products provide early detection and monitoring for patients with NAFLD & NASH when a diagnosis is often missed due to limited screening with low-sensitivity tools. The current standard for diagnosis is risky and costly with mounting evidence calling for an efficacious and cost-effective non-invasive diagnostic tool. Fibronostics' HealthFACTR tool employes technology to predict risk, providing results for risks of coronary heart disease, stroke, diabetes and fatty liver disease. HealthFACTR enables action-oriented recommendations which allow healthcare professions to determine patients' risk levels and drive better patient care.

Industry
Hospitals and Health Care
Company size
11-50 employees
Headquarters
Orlando, Florida
Type
Privately Held
Founded
2015
Specialties
liver, liver health, liver disease, nafld, artificial intelligence, machine learning, non invasive , nash, and med tech

Locations

  • Primary

    3452 Lake Lynda Dr

    Suite 151

    Orlando, Florida 32817, US

    Get directions
  • 79 Science Park Drive,Cintech IV

    #06-01/08

    Singapore, Singapore 118264, SG

    Get directions

Employees at Fibronostics

Updates

Similar pages

Browse jobs